# Relates to requiring homeless shelters to keep an opioid antagonist on hand, have at least one trained employee on duty at all times, and develop a training plan for opioid overdoses

**Bill ID:** A206AA
**Session:** 2023
**Sponsor:** Linda Rosenthal
**Status:** In Assembly Committee
**PDF:** [A206A PDF](https://legislation.nysenate.gov/pdf/bills/2023/A206A)

## Summary

Requires homeless shelters to keep an opioid antagonist on hand at all times and trained personnel when required by applicable law, regulation, code, or operating plan approved by a social services district or the commissioner otherwise requires employees to be at the premises; sets out the requirements for the training of those employees; develops a training plan for opioid overdoses in conjunction with a registered opioid overdose prevention program.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  206--A
 
  2023-2024 Regular Sessions
 
  I N  A S S E M B L Y
 
  (PREFILED)
 
  January 4, 2023
  ___________
 
 Introduced by M. of A. L. ROSENTHAL, STIRPE -- read once and referred to
  the  Committee  on  Social Services -- recommitted to the Committee on
  Social Services in accordance with Assembly Rule 3, sec. 2 -- reported
  and  referred  to  the  Committee  on  Ways  and  Means  --  committee
  discharged, bill amended, ordered reprinted as amended and recommitted
  to said committee
 
 AN  ACT to amend the social services law, in relation to requiring home-
  less shelters to keep an opioid antagonist on hand, have at least  one
  trained  employee  on  duty at all times, and provide an opioid antag-
  onist training program for residents
 
  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Article 2-A of the social services law is amended by adding
 a new title 3 to read as follows:
  TITLE 3
  OPIOID ANTAGONISTS IN HOMELESS SHELTERS
 SECTION 47. OPIOID ANTAGONIST USE AND TRAINING.
  ยง 47. OPIOID ANTAGONIST USE AND TRAINING. 1. ANY PROVIDER OF TEMPORARY
 HOUSING ASSISTANCE, WHICH SHALL INCLUDE, BUT NOT BE LIMITED TO, A FAMILY
 SHELTER, A SHELTER FOR ADULTS, A HOTEL, AN EMERGENCY APARTMENT, A DOMES-
 TIC  VIOLENCE  SHELTER,  A RUNAWAY AND HOMELESS YOUTH SHELTER, OR A SAFE
 HOUSE FOR REFUGEES OPERATING IN THIS STATE SHALL HAVE AT ITS PREMISES:
  (A) AN OPIOID ANTAGONIST AND A METHOD OF ADMINISTERING IT ON  SITE  AT
 ALL TIMES WHICH MAY INCLUDE, BUT NOT BE LIMITED TO, A NALOXONE KIT; AND
  (B)  AT  A  MINIMUM,  ONE EMPLOYEE TRAINED IN THE ADMINISTRATION OF AN
 OPIOID ANTAGONIST ON DUTY AT ALL TIMES WHEN APPLICABLE LAW,  REGULATION,
 CODE,  OR  OPERATING  PLAN APPROVED BY A SOCIAL SERVICES DISTRICT OR THE
 COMMISSIONER OTHERWISE REQUIRES EMPLOYEES TO BE AT THE PREMISES.
  2. ALL EMPLOYEES OF PROVIDERS OF TEMPORARY HOUSING ASSISTANCE WHO  ARE
 AUTHORIZED TO ADMINISTER AN OPIOID ANTAGONIST SHALL:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD00670-02-4
 A. 206--A  2
 
  (A)  HAVE  COMPLETED  AN INITIAL TRAINING PROGRAM, WHICH MAY INCLUDE A
 DEPARTMENT OF HEALTH  REGISTERED  OPIOID  OVERDOSE  PREVENTION  TRAINING
 PROGRAM;
  (B) COMPLETE A REFRESHER TRAINING PROGRAM AT LEAST EVERY TWO YEARS;
  (C)  CONTACT  THE  EMERGENCY  MEDICAL  SYSTEM DURING ANY RESPONSE TO A
 VICTIM OF SUSPECTED DRUG OVERDOSE AND ADVISE IF AN OPIOID ANTAGONIST  IS
 BEING USED;
  (D)  COMPLY  WITH  PROTOCOLS FOR RESPONSE TO VICTIMS OF SUSPECTED DRUG
 OVERDOSE; AND
  (E) REPORT ALL RESPONSES TO VICTIMS OF SUSPECTED DRUG OVERDOSE TO  THE
 DEPARTMENT OF HEALTH.
  3.  ALL  PROVIDERS  OF  TEMPORARY  HOUSING  ASSISTANCE SHALL DEVELOP A
 TRAINING  PLAN  IN  CONJUNCTION  WITH  A  REGISTERED  OPIOID  OVERDOSE
 PREVENTION PROGRAM IN THE APPLICABLE REGION REGARDING THE ADMINISTRATION
 OF  OPIOID  ANTAGONISTS TO ANY INDIVIDUAL RESIDING ON A PROVIDER'S PREM-
 ISES WHO IS AT RISK OF EXPERIENCING OR WITNESSING AN OPIOID OVERDOSE.
  4. FOR THE PURPOSES OF THIS SUBDIVISION, THE TERM "OPIOID  ANTAGONIST"
 SHALL  MEAN  A  FEDERAL FOOD AND DRUG ADMINISTRATION-APPROVED DRUG THAT,
 WHEN ADMINISTERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN PART THE  PHAR-
 MACOLOGICAL  EFFECTS  OF  AN  OPIOID  IN THE BODY AND THAT IS LIMITED TO
 NALOXONE OR OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF  HEALTH  FOR
 THIS  PURPOSE AND "NALOXONE KIT" SHALL MEAN A PREFILLED NALOXONE SYRINGE
 OR NEEDLE-FREE INTRANASAL DRUG DELIVERY DEVICE.
  5. THE COMMISSIONER IS AUTHORIZED TO PROMULGATE RULES AND  REGULATIONS
 NECESSARY FOR THE IMPLEMENTATION OF THIS TITLE.
  ยง  2.  This  act shall take effect on the thirtieth day after it shall
 have become a law. Effective immediately, the addition, amendment and/or
 repeal of any rule or regulation necessary  for  the  implementation  of
 this  act  on its effective date are authorized to be made and completed
 on or before such effective date.